Inogen, Inc. (INGN)
NASDAQ: INGN · Real-Time Price · USD
7.99
+0.03 (0.38%)
At close: Aug 29, 2025, 4:00 PM
7.99
0.00 (-0.06%)
After-hours: Aug 29, 2025, 4:38 PM EDT
Inogen Market Cap
Inogen has a market cap or net worth of $216.05 million as of August 29, 2025. Its market cap has decreased by -25.22% in one year.
Market Cap
216.05M
Enterprise Value
112.66M
1-Year Change
-25.22%
Ranking
Category
Stock Price
$7.99
Market Cap Chart
Since February 14, 2014, Inogen's market cap has decreased from $274.90M to $216.05M, a decrease of -21.41%. That is a compound annual growth rate of -2.06%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 29, 2025 | 216.10M | -1.05% |
Dec 31, 2024 | 218.40M | 70.63% |
Dec 29, 2023 | 128.00M | -71.67% |
Dec 30, 2022 | 451.80M | -41.52% |
Dec 31, 2021 | 772.60M | -21.82% |
Dec 31, 2020 | 988.20M | -34.26% |
Dec 31, 2019 | 1.50B | -43.75% |
Dec 31, 2018 | 2.67B | 7.54% |
Dec 29, 2017 | 2.49B | 82.61% |
Dec 30, 2016 | 1.36B | 72.72% |
Dec 31, 2015 | 787.90M | 34.82% |
Dec 31, 2014 | 584.40M | 112.59% |
Feb 14, 2014 | 274.90M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 659.09B |
Johnson & Johnson | 425.77B |
AbbVie | 367.55B |
UnitedHealth Group | 275.22B |
AstraZeneca | 248.07B |
Novo Nordisk | 246.45B |
Novartis AG | 245.68B |
Abbott Laboratories | 228.80B |